비PVC 의료용 필름 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

Non-Pvc Medical Film Market

The future of the global non-pvc medical film market looks promising with opportunities in the hospital, clinic, home healthcare, and pharmaceutical company markets. The global non-pvc medical film market is expected to reach an estimated $899.1 million by 2035 from $543.2 million in 2027 with a CAGR of 7.5% from 2027 to 2035. The major drivers for this market are the increasing demand for safer medical packaging, the rising adoption of environmentally friendly materials, and the growing use of non-PVC materials in healthcare.

• Lucintel forecasts that, within the material type category, polypropylene is expected to witness the highest growth over the forecast period due to stronger chemical resistance and safer test-strip film comparing polypropylene.
• Within the end use category, home healthcare is expected to witness the highest growth over the forecast period due to in-home health care is growing and requires safe medical packaging.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to more stringent regulations are benefitting the use of non-PVC medical films.

Emerging Trends in Non-Pvc Medical Film Market

By 2027, the non-PVC medical film category is likely to move away from basic barrier films. Additionally, various stakeholders, including converters and end users (e.g., drug packaging and wound care), are becoming more aware of the components used in medical products. For converted medical films to meet stakeholder demands, innovations will likely be required.

• Sustainability: The non-PVC medical films will likely need to be designed to be more sustainable and have lower carbon footprints. From 2025, the European public sector will likely award contracts to companies that provide products made with more sustainable materials.
• Digital Manufacturing: Cameras and real-time analytics, coupled with closed-loop controls, will enable digital sheaths and rolls to be inspected and qualified at very high speeds.
• Functional Products: Demand for PVC-free films used in oxygen and moisture barrier films, diagnostics and drug delivery, will continue to increase.
• Supplier Diversification: Disruptions in the supply of resin and film during 2020 and 2021 showed medical device manufacturers their overreliance on a small number of suppliers. As a result, many have begun evaluating alternative suppliers in North America, Europe and Asia. It is anticipated that between 2025 and 2027, additional capacity will be added to these regional supplies of medical devices. Because of the lack of confidence in global supply, many device manufacturers will be willing to pay higher costs for regional supplies.
• Smart Materials: Combination materials consisting of polyolefins and polyurethanes are being evaluated for use in flexible medical devices. Other materials being researched include biopolymers. These materials are being evaluated for use in medical devices that require flexibility and strength, as well as resistance to sterilization.

Non-PVC medical grade films and devices are expected to displace traditional medical packaging films. Advances in medical device materials are expected to foster the growth of medical devices and related packaging. Adoption of recently developed medical devices and packaging films is expected to provide single digit revenue growth to medical device suppliers through 2030.

Recent Developments in the Non-Pvc Medical Film Market

Non-PVC medical films are expected to increase to 2027 as hospitals and medical device manufacturers' focus turns to using lower extractable materials and structures that are more recyclable and ensure supply chain resiliency. Lucintel also sees a positive outlook for the medical film industry, focusing on lifecycle performance and regulatory market accessibility.

• Acquisition Led Scale: Amcor's acquisition of Berry Global in 2025 created a larger flexible film and packaging supplier to the medical industry. In the next several years, expect greater competition and shorter contract award cycles for medical films.
• Recyclability Regulations: Beginning in 2025, the EU's Packaging and Packaging Waste Directive created a time-bound framework to enhance the analysis of packaging design from a circular economy perspective and to increase the minimum levels of recycled content in packaging. Although medical devices and their packaging continue to be exempt, there is increased pressure on converters to produce documents supporting the rationale for the continued use of non-recycled content in packaging. Therefore, to be fully prepared to meet the demands of the medical device packaging converter, non-PVC medical film should be designed to be fully recyclable and/or multilayer.
• Regional Capacity Investment: Medical packaging producers invested in new production facilities in both North America and Europe in 2025. The investments were in the tens of millions of dollars. Packages produced through these new facilities will alleviate supply chain concerns and decrease the time it takes to replenish inventory.
• Barrier-film Innovation: In 2025, new polyethylene and polypropylene films that can be sterilized and made for contact with body fluids and other substances were released. Suppliers of these films claimed that their products have barrier properties like PVC and PET films. Acceptance of these new films by the healthcare and medical fields will depend on the availability of clinical data.
• Healthcare Consolidation: The initial public offering of Medline in the amount of $4.3 billion in June 2025 illustrated the trend of large medical supply companies. As larger companies control a greater share of the supply, film suppliers that have consistent and stable supplies of medical grade packaging films will be rewarded.

There will be continued emphasis on barrier performance of medical grade packaging films to meet the needs of the regulated medical and healthcare industries. Suppliers of these films that have integrated vertically and have access to stable and reliable feedstocks will likely capture the majority of the packaging contracts through 2030.

Strategic Growth Opportunities in the Non-Pvc Medical Film Market

Non-PVC medical film has the potential to become a standard material. From 2024 to 2026, changes in rules and regulations in the areas of sustainability, packaging, and pharmaceutical supply will place greater demand on converters. According to Lucintel, in the future, the performance and economics of a film will determine its use, rather than the price of the raw material, as is the case today.

• Drug Delivery Packaging: A potential market is in the area of IV drug packaging. Non-PVC films will be used in the production of flexible packets and bags for IV solutions. IV drug packaging will gain further market potential with the implementation of the EU Packaging and Packaging Waste Regulation. This will create further demand for pharmaceutical companies to standardize drug packaging.
• Premium Barrier Films: Temperature sensitive and/or moisture sensitive biologics will require advanced packaging. Additionally, the use of advanced and more effective barrier films will be of greater market potential to offset the loss of low barrier film markets.
• Sustainable Sterile Packaging: Lower environmental impact films that are still compatible with sterilization can help meet priciness targets. The EC will publish detailed guidelines for industry on the packaging requirements of this regulation in the later part of 2025. Currently, the focus is on decreasing the environmental impact of the materials used in medical devices. Sustainable films will be in high demand.
• Emerging Market Conversion: Dependence on medical device packaging made outside the region can be alleviated by setting up local manufacturing and technical services in India, S.E. Asia and Latin America. The Indian pharmaceutical industry is one of the fastest growing in the world. According to the IBEF, the industry was worth $65 billion in 2024. As the regional pharmaceutical industry grows, there will be increased demand for advanced and specialized film by the converters.
• Digital Quality Services: Supplying medical grade films requires lot level inspection and traceability. The alignment of the FDA medical device quality regulation with ISO 13485 will make Data-driven quality services a norm. This will strengthen service contracts.

In the next 3-5 years, suppliers will focus on performance over volume for non-PVC medical films. There will be an emphasis on films that integrate more than one feature such as drug compatibility, CCD, recyclability, and traceability.

Non-Pvc Medical Film Market Drivers and Challenges

Interconnected factors affecting the non-pvc medical film market include development in science and technology, changes in the healthcare industry, global economics, and environmental and legislative policies. Industry and hospital witnessed the need to use PVC alternatives because of the environmental and health concerns related to the use of PVC. According to Lucintel, the competition and the future direction of the market will be determined by the level of innovation in the core technologies (materials, processes and services) and the extent to which players can comply with the prescribed requirements.

The factors responsible for driving this market include:

• Increase in Healthcare Activities: The number of surgical and diagnostic procedures is increasing the need to package and transport medical products in sterile conditions. Medical flexible packaging, including wound dressing and medical device components, is in higher demand, especially in the higher-income countries. As of January, 2025, the World Health Organization stated that about 74% of all worldwide deaths were due to non-communicable diseases, thus, Projecting increased demand for medical services and products. Over the next 3-5 years, it is expected that medical services will be performed outside the traditional medical facilities. Consequently, lightweight and flexible non-PVC medical films will be required.
• Medical Devices: Advances in polyethylene, polypropylene, polyesters, polyurethanes, and multilayer films have improved features such as sealability and barrier protection and have allowed the manufacture of medical devices using non-PVC films. The use of biologic evaluation of materials (BEM) in conformity with ISO 10993 has allowed the selection of materials based upon safety and performance for the intended use. As a result, the medical device industry has targeted non-PVC films for medical device packaging. In the next three to five years, there will be an increasing preference for non-PVC alternatives in packaging films for the medical device industry.
• Initiatives To Reduce Impact on The Environment: Healthcare professionals have reduced their use of PVC and other chlorine-based materials to reduce the impact of their activities on the environment. Non-PVC films have the potential to further reduce the environmental impact of packaging films. The European Union's 2025 Packaging and Packaging Waste Directive was implemented in February 2025 and established rules for the reduction of the impact of packaging on the environment. The directive established rules for an environmental management system for the packaging industry. These will accelerate the shift from PVC-based films to films with a reduced environmental impact.
• Regulatory Support: There is regulatory pressure for extractables and leachable studies, and assessment of biocompatibility and sterilization of medical devices. These creates a trend to evaluate materials based on their potential risks. Thus, materials that are assessed based on their potential risks may gain more acceptance in the medical industry. It is expected that in the coming years, requirements for process control and documentation in the medical industry will further increase, based on the quality system standards.
• Improved Production and New Products: Producers of medical films invest in new technologies for improving the yield and reducing costs for conversion of medical films. New medical films are developed for specific applications. New technologies for medical packaging are developed to improve sealing of medical devices, to minimize leaking of medical devices and to reduce thickness of medical packaging. Inline quality control is employed for assessing sealing and to minimize defects. It is expected that improvements in design and manufacturing of medical devices will further reduce thickness of medical packaging and to enhance the competitiveness of medical devices and packaging in the market.

The challenges facing this market include:

• Higher Costs: Non-PVC options may increase costs for a number of reasons including the use of specialty resins, multilayer structures, and special coatings. Also, smaller production runs can result in higher costs. Smaller production runs are common during the early stages of the product life cycle as a given product is qualified for use. In April 2025, ongoing international market conditions increased packaging industry uncertainty and caused delays in long-term pricing. It is expected that during the next 3 to 5 years, public health conditions and the level of risk associated with medical devices will strongly influence the use of PVC and alternative packaging.
• Regulatory Environment: The replacement of PVC can require a significant amount of testing to demonstrate biocompatibility and evaluation of shelf life, sealing, and mechanical properties. A change in materials can require further validation from users and may affect a producer's regulatory approvals and require changed be to re-qualified to produce a given device. During 2025, medical device companies employed processes to evaluate material changes to manage risk in accordance with ISO 14971. It is expected that during the next 3 to 5 years, processes to evaluate and approve changes in materials to be used in medical devices would vary between jurisdictions and pose challenges for cross border trade.
• Limitations in Supply Chain and Performance: Some of the alternative non-PVC polymers have their own challenges, including limited supplier base, price volatility, and inadequate medical grades. Flexibility and other performances characteristics, including the tolerance to momentary thermo-mechanical stresses, puncture resistance, transparency, and performance in sub-zero temperatures, need to be considered, along with the compatibility with sealing and sterilization equipment. In July 2025, industry players continued efforts to source medical films from multiple suppliers. Between now and then, the medical industry may continue using non-PVC films for less critical medical applications. However, for high-grade medical applications, the industry may rely on PVC.

The use of non-PVC medical films is likely to increase because of the combination of negative public perception of PVC and other medical-related materials, increasing global medical requirements, improvements in medical-related materials, and material innovations. However, the costs associated with these improvements, performance characteristics of the alternative materials, and the supply availability may limit the industry's shift from PVC.

List of Non-Pvc Medical Film Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies non-pvc medical film market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the non-pvc medical film market companies profiled in this report include-

• Greiner Bio-One
• Amcor
• Bemis Company
• Sealed Air Corporation
• Graham Medical
• DuPont
• Medtronic
• Becton Dickinson and Company
• Berry Global
• 3M

Non-Pvc Medical Film Market by Segment

The study includes a forecast for the global non-pvc medical film market by material type, application, end use, and region.

Non-Pvc Medical Film Market by Material Type [Value ($M) from 2019 to 2035]:

• Polyethylene
• Polypropylene
• Polyester

Non-Pvc Medical Film Market by Application [Value ($M) from 2019 to 2035]:

• Medical Packaging
• Medical Dressings
• Surgical Drapes
• Catheter Films

Non-Pvc Medical Film Market by End Use [Value ($M) from 2019 to 2035]:

• Hospitals
• Clinics
• Home Healthcare
• Pharmaceutical Companies
• Others

Non-Pvc Medical Film Market by Region [Value ($M) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Non-Pvc Medical Film Market

Use of non-PVC medical film is expected to increase as a result of reforms in medical procurement, domestic manufacturing, and safer flexible packaging. From 2025 to 2027, it is expected that flexible systems based on polyolefin and TPU would find greater application in infusion therapy and other diagnostic and pharmaceutical products. According to a recent study by Lucintel, these changes have created greater competitiveness in both established and new market structures.

• United States: In 2025, Baxter International's products in the US contained PVC-free and DEHP-free IV solutions. Full implementation of the Drug Supply Chain Security Act (DSCSA) by the FDA in October 2025 is expected to create a more level-playing field for domestic suppliers of films, bags and components. In the ensuing years, active health-care organizations would give more preference to suppliers of traceable and compliant medical products.
• China: In January 2025, the China Food and Drug Administration prioritized strengthening of medical device registration and quality assurance. Concurrently, several domestic companies invested in the production of polyolefin-based infusion bags and pharmaceutical films. It is expected that in the next three to five years, the Chinese public health care sector would give more preference to domestic suppliers of medical devices containing non-PVC materials.
• Germany: Packaging legislation combined with the continued sale of PVC- and DEHP-containing infusion systems encouraged the development of Advanced Recycling of multilayer packaging, demonstrated the safety of the contained materials, and/or encouraged investment in the production of advanced recycling of multilayer packaging for the medical industry in Germany. Fresenius Kabi continues to manufacture and sell PVC- and DEHP-based infusion systems in Germany. This legislation will also help accomplish the same for other European Union member states.
• India: The Indian Department of Pharmaceuticals (DoP) extended its incentive scheme for the local manufacturing of infusion and other medical consumables in the country through its National Medical Devices Policy (2019-2024). One of the major beneficiaries of this policy was Poly Medicure, which reported INR 1,485 crore (USD 184 million) revenue in FY 2024-25. Other domestic companies are also expected to invest in manufacturing consumables to offset the import of medical devices, including packaging.
• Japan: The Ministry of Health, Labour and Welfare of Japan revised the national health insurance reimbursement policy to incorporate lower reimbursement rates for a number of medical devices, including infusion pumps and other disposable medical devices. Japanese companies are expected to shift to the use of low- or no-extractables medical devices as part of the policy reforms for the next decade.

Features of the Global Non-Pvc Medical Film Market

• Market Size Estimates: non-pvc medical film market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: non-pvc medical film market size by material type, application, end use, and region in terms of value ($B).
• Regional Analysis: non-pvc medical film market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different material types, applications, end uses, and regions for the non-pvc medical film market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the non-pvc medical film market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the non-pvc medical film market by material type (polyethylene, polypropylene, and polyester), application (medical packaging, medical dressings, surgical drapes, and catheter films), end use (hospitals, clinics, home healthcare, pharmaceutical companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Non-PVC Medical Film Market by Material Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Material Type
• 4.3 Polyethylene : Trends and Forecast 2019 to 2035
• 4.4 Polypropylene : Trends and Forecast 2019 to 2035
• 4.5 Polyester : Trends and Forecast 2019 to 2035

5. Global Non-PVC Medical Film Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Medical Packaging : Trends and Forecast 2019 to 2035
• 5.4 Medical Dressings : Trends and Forecast 2019 to 2035
• 5.5 Surgical Drapes : Trends and Forecast 2019 to 2035
• 5.6 Catheter Films : Trends and Forecast 2019 to 2035

6. Global Non-PVC Medical Film Market by End Use

• 6.1 Overview
• 6.2 Attractiveness Analysis by End Use
• 6.3 Hospitals : Trends and Forecast 2019 to 2035
• 6.4 Clinics : Trends and Forecast 2019 to 2035
• 6.5 Home Healthcare : Trends and Forecast 2019 to 2035
• 6.6 Pharmaceutical Companies : Trends and Forecast 2019 to 2035
• 6.7 Others : Trends and Forecast 2019 to 2035

7. Regional Analysis

• 7.1 Overview
• 7.2 Global Non-PVC Medical Film Market by Region

8. North American Non-PVC Medical Film Market

• 8.1 Overview
• 8.2 North American Non-PVC Medical Film Market by Material Type
• 8.3 North American Non-PVC Medical Film Market by End Use
• 8.4 The United States Non-PVC Medical Film Market
• 8.5 Canadian Non-PVC Medical Film Market
• 8.6 Mexican Non-PVC Medical Film Market

9. European Non-PVC Medical Film Market

• 9.1 Overview
• 9.2 European Non-PVC Medical Film Market by Material Type
• 9.3 European Non-PVC Medical Film Market by End Use
• 9.4 German Non-PVC Medical Film Market
• 9.5 French Non-PVC Medical Film Market
• 9.6 Italian Non-PVC Medical Film Market
• 9.7 Spanish Non-PVC Medical Film Market
• 9.8 The United Kingdom Non-PVC Medical Film Market

10. APAC Non-PVC Medical Film Market

• 10.1 Overview
• 10.2 APAC Non-PVC Medical Film Market by Material Type
• 10.3 APAC Non-PVC Medical Film Market by End Use
• 10.4 Chinese Non-PVC Medical Film Market
• 10.5 Indian Non-PVC Medical Film Market
• 10.6 Japanese Non-PVC Medical Film Market
• 10.7 South Korean Non-PVC Medical Film Market
• 10.8 Indonesian Non-PVC Medical Film Market

11. ROW Non-PVC Medical Film Market

• 11.1 Overview
• 11.2 ROW Non-PVC Medical Film Market by Material Type
• 11.3 ROW Non-PVC Medical Film Market by End Use
• 11.4 Middle Eastern Non-PVC Medical Film Market
• 11.5 South American Non-PVC Medical Film Market
• 11.6 African Non-PVC Medical Film Market

12. Competitor Analysis

• 12.1 Product Portfolio Analysis
• 12.2 Operational Integration
• 12.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 12.4 Market Share Analysis

13. Opportunities & Strategic Analysis

• 13.1 Value Chain Analysis
• 13.2 Growth Opportunity Analysis
  • 13.2.1 Growth Opportunity by Material Type
  • 13.2.2 Growth Opportunity by Application
  • 13.2.3 Growth Opportunity by End Use
• 13.3 Emerging Trends in the Global Non-PVC Medical Film Market
• 13.4 Strategic Analysis
  • 13.4.1 New Product Development
  • 13.4.2 Certification and Licensing
  • 13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain

• 14.1 Competitive Analysis Overview
• 14.2 Greiner BioOne
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.3 Amcor
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.4 Bemis Company
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.5 Sealed Air Corporation
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.6 Graham Medical
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.7 DuPont
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.8 Medtronic
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.9 Becton Dickinson and Company
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.10 Berry Global
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.11 3M
  • Company Overview
  • Non-PVC Medical Film Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

15. Appendix

• 15.1 List of Figures
• 15.2 List of Tables
• 15.3 Research Methodology
• 15.4 Disclaimer
• 15.5 Copyright
• 15.6 Abbreviations and Technical Units
• 15.7 About Us
• 15.8 Contact Us